San Diego-centered Viking Therapeutics marked alone as a serious competitor from the weight loss drug industry in February after revealing promising details from the mid-phase trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when provided like a weekly injection and in March the company unveil… Read More